Neuro-Oncology News

Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a randomized observational study.

The promise of immune checkpoint inhibitors in systemic cancers such as melanoma, non-small-cell lung cancer and breast cancer has prompted researchers to start examining the potential for these immunotherapies in the management of primary and metastatic brain tumors, according to Peter A. Forsyth, MD, FACP, MA, of the H. Lee Moffitt Cancer Center & Research Institute at the University of Southern Florida.

Novel therapies are beginning to refute the dogma that immune therapy does not work in patients with primary brain tumors, according to Manmeet Ahluwalia, MD, director of the Brain Metastases Research Program at the Cleveland Clinic and neuro-oncology section editor for HemOnc Today.

Underrepresentation of Hispanic patients and children aged 0 to 4 years occurred frequently in phase 1 trials, according to a meta-analysis of trials conducted by Children’s Oncology Group and Pediatric Brain Cancer Consortium.

Memorial Sloan Kettering Cancer Center launched a new initiative designed to help teens and young adults with cancer.

The risk for endocrinopathies increased substantially over time among childhood cancer survivors, especially among those who received high-risk therapies, according to the results of an analysis from the Childhood Cancer Survivor Study.

The FDA granted rare pediatric disease designation to ABT-414 for the treatment of children with epidermal growth factor receptor–amplified diffuse intrinsic pontine glioma.

Cancer treatment centers in the United States spent $173 million on advertising in the year 2014, according to a research letter published in JAMA Internal Medicine.

The FDA approved dronabinol oral solution for the treatment of patients with cancer who experience chemotherapy-induced nausea and vomiting, according to a press release from the agent’s manufacturer.

Short sleep duration and frequent snoring prior to cancer diagnosis may shorten OS among postmenopausal women with breast cancer.